Drug Shortage Report for DESIPRAMINE
| Report ID | 219719 |
| Drug Identification Number | 02216256 |
| Brand name | DESIPRAMINE |
| Common or Proper name | DESIPRAMINE |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DESIPRAMINE HYDROCHLORIDE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | N06AA |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-02-15 |
| Actual start date | |
| Estimated end date | 2024-04-09 |
| Actual end date | 2024-04-09 |
| Shortage status | Resolved |
| Updated date | 2024-04-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-04-11 | French | Compare |
| v8 | 2024-04-11 | English | Compare |
| v7 | 2024-04-04 | French | Compare |
| v6 | 2024-04-04 | English | Compare |
| v5 | 2024-02-29 | French | Compare |
| v4 | 2024-02-29 | English | Compare |
| v3 | 2024-02-16 | English | Compare |
| v2 | 2024-02-15 | French | Compare |
| v1 | 2024-02-15 | English | Compare |
Showing 1 to 9 of 9